Category: All our news

Publications

Breast Cancer

MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC

News

XenTech remains fully operational after 7 weeks of COVID-19 pandemic : update from our COO

In this 7th week of containment and as end of confinement in France is announced for May 11th, I would first of all like to thank you on behalf of our teams for all the messages of support you have sent us since the beginning of the COVID-19 crisis.

Discover

News

XenTech Covid-19 management

Regarding the current circumstances, we at XenTech want you to know that we are taking the Covid-19 pandemia very seriously. We are closely monitoring the pandemic, following guidance and advice from the World Health Organization (WHO), and the French Government.

Discover